Categories
-
Wal-Mart
- General Motors
- Dow Jones
- Goldman Sachs
- Accor
- Renault
- Reuters
- BNP Paribas
- Toyota
- AgBank
- Microsoft
- Intel
- ALCATEL-LUCENT
- AXA
- Japan Airlines
- Agricultural Bank of China
- Lucien Barri
- CITIGROUP
- toutes nos catégories
Tags
Intellipharmaceutics announces dismissal of patent litigation settlement on Focalin XR drugIntellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR® ...
2010-05-15 - News-Medical-Net